|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|